Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10th Anniversary Conference.

Abstract:

:In 2006, a remarkable collaboration between University of Texas MD Anderson Cancer Center clinicians and Texas and New Mexico State legislators led to the formation of a dedicated IBC Research Program and Clinic at MD Anderson. This initiative provided funding and infrastructure to foster coordination of an IBC World Consortium of national and international experts, and launch the first ever IBC international conference in 2008, which brought together experts from around the world to facilitate collaborations and accelerate progress. Indeed great progress has been made since then. National and international experts in IBC convened at the 10th Anniversary Conference of the MD Anderson IBC Clinic and Research Program and presented the most extensive sequencing analysis to date comparing IBC to non-IBC, gene- and protein-based immunoprofiling of IBC versus non-IBC patients, and converging lines of evidence on the specific role of the microenvironment in IBC. Novel models, unique metabolic mechanisms, and prominent survival pathways have been identified and were presented. Multiple clinical trials based on the work of the last decade are in progress or in development. The important challenges ahead were discussed. This progress and a coordinated summary of these works are presented herein.

journal_name

J Cancer

journal_title

Journal of Cancer

authors

Woodward WA,Cristofanilli M,Merajver SD,Van Laere S,Pusztai L,Bertucci F,Berditchevski F,Polyak K,Overmoyer B,Devi GR,Sterneck E,Schneider R,Debeb BG,Wang X,van Golen KL,El-Zein R,Rahal OM,Alexander A,Reuben JM,Kris

doi

10.7150/jca.21200

subject

Has Abstract

pub_date

2017-10-09 00:00:00

pages

3607-3614

issue

17

issn

1837-9664

pii

jcav08p3607

journal_volume

8

pub_type

杂志文章
  • Glioblastoma Treatment Modalities besides Surgery.

    abstract::Glioblastoma multiforme (GBM) is commonly known as the most aggressive primary CNS tumor in adults. The mean survival of it is 14 to 15 months, following the standard therapy from surgery, chemotherapy, to radiotherapy. Efforts in recent decades have brought many novel therapies to light, however, with limitations. In...

    journal_title:Journal of Cancer

    pub_type: 杂志文章,评审

    doi:10.7150/jca.32475

    authors: Zhang H,Wang R,Yu Y,Liu J,Luo T,Fan F

    更新日期:2019-08-27 00:00:00

  • Statistics and pitfalls of trend analysis in cancer research: a review focused on statistical packages.

    abstract::Trend analysis is the analysis using statistical models to estimate and predict potential trends over time, space or any independent continuous-variable. It has been widely used in epidemiology and public health, but much less so in clinical oncology and basic cancer research. Methodological imitations of the chosen s...

    journal_title:Journal of Cancer

    pub_type: 杂志文章,评审

    doi:10.7150/jca.43521

    authors: Xu J,Lin Y,Yang M,Zhang L

    更新日期:2020-03-04 00:00:00

  • Cytochalasin H Inhibits Angiogenesis via the Suppression of HIF-1α Protein Accumulation and VEGF Expression through PI3K/AKT/P70S6K and ERK1/2 Signaling Pathways in Non-Small Cell Lung Cancer Cells.

    abstract::Our previous study has demonstrated that cytochalasin H (CyH) isolated from mangrove-derived endophytic fungus induces apoptosis and inhibits migration in A549 non-small cell lung cancer (NSCLC) cells. In this study, we further explored the effect of CyH on angiogenesis in NSCLC cells and the underlying molecular mech...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.29933

    authors: Ma Y,Xiu Z,Zhou Z,Huang B,Liu J,Wu X,Li S,Tang X

    更新日期:2019-05-12 00:00:00

  • Capecitabine plus Oxaliplatin as a Second-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Phase II Trial.

    abstract::Background: Although biliary tract cancer (BTC) has a very aggressive nature, some patients maintain a relatively good performance status after failure with first-line treatment of gemcitabine plus cisplatin (GC). Thus, tolerable, feasible, and useful second-line treatments are needed for these patients. We investigat...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.37610

    authors: Kim ST,Oh SY,Lee J,Kang JH,Lee HW,Lee MA,Sohn BS,Hong JH,Park YS,Park JO,Lim HY

    更新日期:2019-10-15 00:00:00

  • Small Nucleolar RNA 71A Promotes Lung Cancer Cell Proliferation, Migration and Invasion via MAPK/ERK Pathway.

    abstract::Objective: Increasing evidence suggested that dysregulated small nucleolar RNAs (snoRNAs) were involved in tumor development. The roles of snoRNA 71A (SNORA71A) in the progression of non-small cell lung cancer (NSCLC) remained unclear. Methods: Dataset GSE19188 from Gene Expression Omnibus (GEO) database was downloade...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.31077

    authors: Tang G,Zeng Z,Sun W,Li S,You C,Tang F,Peng S,Ma S,Luo Y,Xu J,Tian X,Zhang N,Gong Y,Xie C

    更新日期:2019-05-21 00:00:00

  • Phosphorylated Protein Kinase C (Zeta/Lambda) Expression in Colorectal Adenocarcinoma and Its Correlation with Clinicopathologic Characteristics and Prognosis.

    abstract::Background: Protein kinase C zeta/lambda (PKCζ/λ) is a family of protein kinase enzymes that contributes to cell proliferation and regulation, which are important for cancer development. PKCζ/λ has been shown to be an important regulator of tumorigenesis in intestinal cancer. The phosphorylated form of PKCζ/λ, p-PKCζ/...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.20983

    authors: Yeo MK,Kim JY,Seong IO,Kim JM,Kim KH

    更新日期:2017-09-20 00:00:00

  • Survival benefit of adjuvant chemotherapy for patients with poorly differentiated stage IIA colon cancer.

    abstract::Background: The effect of adjuvant chemotherapy on stage II colon cancer remains constantly controversial. Recently, however, several studies have reported the definite survival benefit of adjuvant chemotherapy (ACT) in T4 disease (stage IIB and IIC) among stage II colon cancer patients. The following study investigat...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.28917

    authors: Liu Q,Luo D,An H,Zhang S,Cai S,Li Q,Li X

    更新日期:2019-01-29 00:00:00

  • Synergy of purine-scaffold TLR7 agonist with doxorubicin on systemic inhibition of lymphoma in mouse model.

    abstract::Chemo- and radio-therapy suffer from certain well-recognized drawbacks for lymphoma therapy. Passive immunotherapy with monoclonal antibody has improved outcome for patients with CD20+ B cell lymphoma, but not for T cell lymphoma. Therefore, novel treatment approaches are clearly required for T cell lymphoma. To date,...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.20015

    authors: Gao D,Li W,Wang W,Cai Y,Wang Y,Luo X,Wei CC

    更新日期:2017-09-15 00:00:00

  • Systematic Analysis of Gene Expression Alteration and Co-Expression Network of Eukaryotic Initiation Factor 4A-3 in Cancer.

    abstract::Purpose: Eukaryotic initiation factor 4A-3 (EIF4A3) is an RNA-binding protein (RBP) that is a core component of the exon junction complex (EJC). It has been identified as an important player in post-transcriptional regulation processes. Recently, investigations have focused on EIF4A3 dysfunction in carcinogenesis. The...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.27655

    authors: Lin Y,Zhang J,Cai J,Liang R,Chen G,Qin G,Han X,Yuan C,Liu Z,Li Y,Zou D,Mao Y

    更新日期:2018-11-11 00:00:00

  • Netrin-1 promotes cell neural invasion in gastric cancer via its receptor neogenin.

    abstract::Neural invasion (NI) is one of the important routes for local spread of gastric cancer (GC) correlated with poor prognosis. However, the exact cellular characteristics and molecular mechanisms of NI in GC are still unclear. Netrin-1(NTN1) as an axon guidance molecule was firstly found during neural system development....

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.30230

    authors: Yin K,Wang L,Xia Y,Dang S,Zhang X,He Z,Xu J,Shang M,Xu Z

    更新日期:2019-06-02 00:00:00

  • Chloroma/Granulocytic sarcoma: abdominal & pelvic presentation of acute myelogenous leukemia.

    abstract::There is limited literature documenting granulocytic sarcoma of the colon. We report a case of a 28 year-old female with a colonic granulocystic sarcoma of the colon as a complication of AML, as it is an important consideration with surgical management of typhilitis. ...

    journal_title:Journal of Cancer

    pub_type:

    doi:10.7150/jca.1.98

    authors: Tsikitis VL,Corning C,Henderson J,Rose J

    更新日期:2010-07-14 00:00:00

  • Multifaceted Mechanisms of Areca Nuts in Oral Carcinogenesis: the Molecular Pathology from Precancerous Condition to Malignant Transformation.

    abstract::Oral cancer is one of the most frequent malignant diseases worldwide, and areca nut is a primary carcinogen causing this cancer in Southeast Asia. It has been widely reported that areca nut induced several cytotoxic effects in oral cells, including ROS generation, inflammation, tissue hypoxia, DNA damage, and cell inv...

    journal_title:Journal of Cancer

    pub_type: 杂志文章,评审

    doi:10.7150/jca.29765

    authors: Li YC,Cheng AJ,Lee LY,Huang YC,Chang JT

    更新日期:2019-07-08 00:00:00

  • EHMT2 inhibitor BIX-01294 induces endoplasmic reticulum stress mediated apoptosis and autophagy in diffuse large B-cell lymphoma cells.

    abstract::Despite advancement in the treatment of diffuse large B-cell lymphoma (DLBCL), many patients tend to relapse or become refractory after initial therapy. Therefore, it is essential to identify novel therapeutic targets and drugs, understand the molecular pathogenesis mechanism of DLBCL, and find ways to prevent and tre...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.48310

    authors: Xu L,Gao X,Yang P,Sang W,Jiao J,Niu M,Liu M,Qin Y,Yan D,Song X,Sun C,Tian Y,Zhu F,Sun X,Zeng L,Li Z,Xu K

    更新日期:2021-01-01 00:00:00

  • R.E.N.A.L. Nephrometry Score: A Preoperative Risk Factor Predicting the Fuhrman Grade of Clear-Cell Renal Carcinoma.

    abstract::Objective: The purpose of this study was to evaluate the efficacy and feasibility of the R.E.N.A.L. Nephrometry Score to postoperatively predict high-grade clear-cell renal carcinoma (ccRCC). Methods: The study included 288 patients diagnosed with ccRCC who had complete CT/CTA data and R.E.N.A.L. Nephrometry Scores an...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.21189

    authors: Chen SH,Wu YP,Li XD,Lin T,Guo QY,Chen YH,Huang JB,Wei Y,Xue XY,Zheng QS,Xu N

    更新日期:2017-10-17 00:00:00

  • Risk Factors Associated with Precancerous Lesions of Esophageal Squamous Cell Carcinoma: a Screening Study in a High Risk Chinese Population.

    abstract::Background: Esophageal squamous cell carcinoma (ESCC) has been having a high mortality rate in China. Most patients are diagnosed in advanced stages, leading to the poor prognosis and low 5-year survival rate. Detection of precancerous lesions or early cancers is the key to improving this situation. Although previous ...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.29979

    authors: Sun Y,Zhang T,Wu W,Zhao D,Zhang N,Cui Y,Liu Y,Gu J,Lu P,Xue F,Yu J,Wang J

    更新日期:2019-06-02 00:00:00

  • Inhibition of Phospholipase D1 mRNA Expression Slows Down the Proliferation Rate of Prostate Cancer Cells That Have Transited to Androgen Independence.

    abstract::To explore the role of phospholipase D1 (PLD1) mRNA in transition of prostate cancer (PCa) cells to androgen independence, we used Arraystar Human LncRNA Microarray V3.0 to detect and compare the differential expression of PLD1 and its signaling pathway-related gene in standard androgen dependence prostate cancer (ADP...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.26689

    authors: Zhou W,Shi K,Ji L,Wu R,Chen Y,Tu H,Zhou B,Wang Z,Zhang M

    更新日期:2018-09-08 00:00:00

  • The Expression of Perilipin Family Proteins can be used as Diagnostic Markers of Liposarcoma and to Differentiate Subtypes.

    abstract::Objective: Liposarcoma is a mesenchymal malignant tumor characterized by adipocyte differentiation which is divided into four subtypes with different prognosis. Accurate histopathological diagnosis is essential for precise treatment. Perilipins, including PLIN1, PLIN2, PLIN3, PLIN4, PLIN5, is a family of lipid droplet...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.41736

    authors: Zhang Q,Zhang P,Li B,Dang H,Jiang J,Meng L,Zhang H,Zhang Y,Wang X,Li Q,Wang Y,Liu C,Li F

    更新日期:2020-04-07 00:00:00

  • Inhibition of Tumor Lymphangiogenesis is an Important Part that EGFR-TKIs Play in the Treatment of NSCLC.

    abstract::Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been widely used to treat non-small cell lung cancer (NSCLC) because they inhibit tumour growth and metastasis. However, the underlying mechanisms are not fully understood. Here, we investigate whether anti-lymphangiogenesis mechanisms cont...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.35448

    authors: Zhang Y,Yang X,Liu H,Cai M,Shentu Y

    更新日期:2020-01-01 00:00:00

  • Decreased KPNB1 Expression is Induced by PLK1 Inhibition and Leads to Apoptosis in Lung Adenocarcinoma.

    abstract::Lung cancer is a major cause of death worldwide, with lung adenocarcinoma being the most frequently diagnosed subtype in Japan. Finding the target of an anticancer drug can improve lung adenocarcinoma treatments. Polo-like kinase 1 (PLK1) is an essential mitotic kinase in mitotic progression, and PLK1 inhibition induc...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.21802

    authors: Sekimoto N,Suzuki Y,Sugano S

    更新日期:2017-11-06 00:00:00

  • A meta-analysis of the short- and long-term results of randomized controlled trials that compared laparoscopy-assisted and conventional open surgery for colorectal cancer.

    abstract:PURPOSE:We conducted a meta-analysis to evaluate and compare the short- and long-term results of laparoscopic colorectal surgery (LCRS) and conventional open surgery (OCRS) for colorectal cancer (CRC). METHODS:We searched relevant papers published between January 1990 and May 2011. We analyzed the outcomes of each typ...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.2.425

    authors: Ohtani H,Tamamori Y,Arimoto Y,Nishiguchi Y,Maeda K,Hirakawa K

    更新日期:2011-01-01 00:00:00

  • Effect of Lipophilic and Hydrophilic Statins on Breast Cancer Risk in Thai Women: A Cross-sectional Study.

    abstract:BACKGROUND:Statins are proposed as a chemoprevention agent for breast cancer due to their anti-inflammatory effect. The effects of lipophilic and hydrophilic statins on breast cancer risk might be different due to their different pharmacologic properties. Therefore, this study aimed to assess a casual-effect of lipophi...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.14941

    authors: Anothaisintawee T,Udomsubpayakul U,McEvoy M,Lerdsitthichai P,Attia J,Thakkinstian A

    更新日期:2016-06-06 00:00:00

  • Perspectives of breast cancer thermotherapies.

    abstract::In this article, the use of different types of thermotherapies to treat breast cancer is reviewed. While hyperthermia is most commonly used as an adjuvant in combination with radiotherapy, chemotherapy, targeted therapy or cryotherapy to enhance the therapeutic effect of these therapies, thermoablation is usually carr...

    journal_title:Journal of Cancer

    pub_type: 杂志文章,评审

    doi:10.7150/jca.8693

    authors: Alphandéry E

    更新日期:2014-05-29 00:00:00

  • Significantly higher pathologic complete response (pCR) after the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: Evidence from a meta-analysis of randomized controlled trials.

    abstract::Objectives: To investigate the effect of the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy (NAC) for HER2-positive breast cancer in terms of pCR and cardiotoxicity. Methods: We systematically searched Pubmed, Embase, Cochrane and SinoMed databases from inception until 1 July 2017 for r...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.24701

    authors: Wu YT,Xu Z,Arshad B,Wu JS,Zhang K,Wu H,Li X,Li H,Li YC,Wang ZL,Wu KN,Kong LQ

    更新日期:2018-08-06 00:00:00

  • GSTP1 Ile105Val polymorphism might be associated with the risk of radiation pneumonitis among lung cancer patients in Chinese population: A prospective study.

    abstract::Background: Growing data suggest that DNA damage repair and detoxification pathways play crucial roles in radiation-induced toxicities. To determine whether common functional single-nucleotide polymorphisms (SNPs) in candidate genes from these pathways can be used as predictors of radiation pneumonitis (RP), we conduc...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.20643

    authors: Du L,Yu W,Huang X,Zhao N,Liu F,Tong F,Zhang S,Niu B,Liu X,Xu S,Huang Y,Dai X,Xie C,Chen G,Cong X,Qu B

    更新日期:2018-02-01 00:00:00

  • Weaknesses and Pitfalls of Using Mice and Rats in Cancer Chemoprevention Studies.

    abstract::Many studies, using different chemical agents, have shown excellent cancer prevention efficacy in mice and rats. However, equivalent tests of cancer prevention in humans require decades of intake of the agents while the rodents' short lifespans cannot give us information of the long-term safety. Therefore, animals wit...

    journal_title:Journal of Cancer

    pub_type: 杂志文章,评审

    doi:10.7150/jca.12519

    authors: Ma Y,Jia Y,Chen L,Ezeogu L,Yu B,Xu N,Liao DJ

    更新日期:2015-09-01 00:00:00

  • A Phase II Study of Concurrent Docetaxel, Epirubicin and Cyclophosphamide as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer.

    abstract:BACKGROUND:Neoadjuvant chemotherapy with concurrent docetaxel, doxorubicin and cyclophosphamide is commonly used for patients with locally advanced breast cancer. Epirubicin is another anthracycline used in breast cancer but the concurrent use of epirubicin and taxane is not well-established. We conducted a single inst...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.3980

    authors: Yao X,Hosenpud J,Chitambar CR,Charlson J,Cheng YC

    更新日期:2012-01-01 00:00:00

  • The JAM-B/c-src/MMP9 pathway is associated with progression and regulates the invasion of pancreatic cancer.

    abstract::Junctional adhesion molecule B (JAM-B) is a multifunctional transmembrane protein that plays an important role in tumor progression. JAM-B is significantly upregulated in gastric cancer, melanoma cell metastasis and oral squamous cell carcinoma. JAM-2 may also function as a putative tumor suppressor in the progression...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.40953

    authors: Zhang W,He R,Chen S,Zhang L,Cao G,Yang W,Li J

    更新日期:2020-03-05 00:00:00

  • VEGFR-2 Inhibitor Apatinib Hinders Endothelial Cells Progression Triggered by Irradiated Gastric Cancer Cells-derived Exosomes.

    abstract::Background: Radiotherapy is a standard treatment for a significant fraction of cancer patients. Nonetheless, to this day radiation resistance is a key impediment in gastric cancer (GC) treatment. Moreover, GC is characterized by its substantial neo-angiogenesis, driven by high levels of vascular endothelial growth fac...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.25370

    authors: Li G,Lin H,Tian R,Zhao P,Huang Y,Pang X,Zhao L,Cao B

    更新日期:2018-10-18 00:00:00

  • Activation or suppression of the immune response mediators in biliary tract cancer (BTC) patients: a systematic review and meta-analysis.

    abstract::Background: Infiltration of immune cells and immune microenvironment determine the proliferative activity of the tumor and metastasis. The aim of this study was to analyze the influence of activation or suppression of the immune response mediators on the prognosis of biliary tract cancer (BTC). Methods: We searched Pu...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.16774

    authors: Wang Y,Ding M,Zhang Q,Wang J,Yang X,Zhou F,Li L,Yuan Z,Jin H,Qian Q

    更新日期:2017-01-01 00:00:00

  • In Surgical Colon Cancer Patients Extended-Duration Thromboprophylaxis (30 days) with the Highest Dose of Tinzaparin (4,500 IU s.c./q.d.) Normalizes the Postoperative VEGF Levels.

    abstract::Background/Purpose: In colon cancer (CC) patients preoperative (pre-op) levels of VEGF-A165 (VEGF) is a strong predictor for disease recurrence. Elevated postoperative (post-op) VEGF levels could have undesirable effects by enhancing tumor growth and metastasis formation. It has been suggested that thromboprophylaxis ...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.20107

    authors: Mitsis M,Koliou P,Bali C,Ntounousi E,Tatsis V,Nousias V,Lianos GD,Vartholomatos G,Nastos D

    更新日期:2017-08-25 00:00:00